期刊文献+

复方左炔诺孕酮/雌二醇透皮吸收贴片的研制 被引量:1

Study on Transdermal Compound Levonorgestrel and Estradiol Patch
原文传递
导出
摘要 目的考察研制的复方左炔诺孕酮/雌二醇(LNG/E2)透皮吸收贴片的渗透性。方法采用Valia-Chien双室渗透池进行体外经皮渗透实验,以HPLC测定药物浓度求算168h内的渗透量。结果8%月月月月酮、30%丙二醇、4%聚乙二醇400为混合促进剂,LNG和E2的含量分别为4mg·20cm-2,2.5mg·20cm-2时,研制的LNG/E2透皮贴片能使LNG和E2分别以65和43μg·d-1的速率透过人离体皮肤,黏着性较好。结论LNG和E2的体外人体皮肤渗透率可达避孕贴片设计要求。 OBJECTIVE To investigate the permeation of transdermal compound levonorgestrel (LNG) and estradiol (E2) patch. METHODS Transdermal permeability of LNG and E2 were carried out by using Valia-Chien double-compartment permeation cell and the permeation amounts of LNG and E2 within 168 h in vitro were examined by HPLC. RESULTS The LNG and E2 permeated through the human skin with different rates at 65 and 43 μg·d^-1 respectively while the enhancers were composed of 8% azone, 30% propylene glycol and 4% polyethylene glycol and the contents of LNG and E2 in patch were 4 and 2.5 mg.20 cm^-2 respectively. The adhesiveness of patch was good. CONCLUSION The human skin permeation rates of LNG and E2 can meet the requirement of contraception.
作者 王俏 陈国神
出处 《中国药学杂志》 CAS CSCD 北大核心 2009年第8期598-601,共4页 Chinese Pharmaceutical Journal
基金 浙江省计划生育委员会项目
关键词 左炔诺孕酮 雌二醇 贴片 透皮给药系统 levonorgestrel estradiol patch transdermaldeliverysystem
  • 相关文献

参考文献13

  • 1SHULMAN L P. 17 Beta-estradiol/levonorgestrel transdermal system for the management of the symptomatic menopausal woman[J]. Expert Opin Pharmacother, 2004, 5(12): 2559-2566.
  • 2VON HOLST T, SALBACH B. Efficacy of a new 7-day transdermal sequential estradiol/levonorgestrel patch in women[J]. Maturitas, 2002, 41(3): 231-242.
  • 3CHEN G S, KIM D D, CHIEN Y W. Dual-controlled transdermal delivery of levonorgestrel and estradiol: enhanced permeation and modulated delivery[J]. J Controlled Release, 1995, 34:129-143.
  • 4FRIEND D, CATZ P, HELLER J, et al. Transdermal delivery of levonorgestrel Ⅰ: Alkanols as permeation enhancers in vitro[J]. J Controlled Release, 1988, 7: 243-250.
  • 5FRIEND D R, CATZ P, HELLER J, et al. Transdermal delivery of levonorgestrel Ⅳ: Evaluation of membranes[J]. J Pharm Sci, 1989, 78(6): 477-480.
  • 6LANDGREN B M, AEDO A R, JOHANNISSON E, et al. Studies on a vaginal ring releasing levonorgestrel at an initial rate of 27 micrograms/24 h when used alone or in combination with transdermal systems releasing estradiol[J]. Contraception, 1994, 50(1): 87-100.
  • 7FRIEND D R, CATZ P, PHILLIPS S. Transdermal delivery of levonorgestrel. VII. In vivo studies[J]. Contraception, 1989, 40(1): 73-80.
  • 8FRIEND D R. Transdermal delivery of levonorgestrel[J]. Med Res Rev, 1991, 11(1): 49-80.
  • 9陈国神,张美云,王俏,叶金翠,周晓飞.复方18甲基炔诺酮透皮控释传递系统的LNG人体药物动力学与药效学评价[J].中国计划生育学杂志,1997,5(5):263-264. 被引量:5
  • 10王俏,邵斌,陈国神.EVAc膜及促进剂对左炔诺孕酮人皮肤渗透速率的影响[J].中国药学杂志,1998,33(11):665-668. 被引量:4

二级参考文献5

共引文献9

同被引文献15

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部